Gilead Sciences's office in France: BoulogneBillancourt, France
Business Address: 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France
Phone: +331 46 09 41 00, 01 80 87 39 30
E-mail: FRMed.Info@gilead.com, communicationfrance@gilead.com
Web: https://signalement.social-sante. gouv.fr, http://ansm.sante.fr, https://www.gilead.fr
| Type | Public |
|---|---|
| Traded as |
|
| Industry |
|
| Founded | June 22, 1987 (1987-06-22) |
| Headquarters | Foster City, California, United States |
| Area served | Worldwide |
| Key people |
|
| Products |
|
| Revenue |  US$27.31 billion (2021) |
| Operating income | US$9.92 billion (2021) |
| Net income | US$6.23 billion (2021) |
| Total assets |  US$67.95 billion (2021) |
| Total equity | US$21.06 billion (2021) |
| Number of employees | 14,400 (2021) |
At Gilead, we’re committed to creating possible. For more than 30 years, we’ve pursued the impossible, chased it down, tackled it for answers and surrounded it for a way in. We have worked tirelessly to bring forward medicines for life-threatening diseases. Through bold and transformative science, we’re creating possibilities that have the potential to become the next generation of life-changing medicines. Our ambition is evident in our mission. Because the impossible is not impossible. It’s what’s next.